[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.196.37. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1961

Novobiocin and Neonatal HyperbilirubinemiaAn Investigation of the Relationship in an Epidemic of Neonatal Hyperbilirubinemia

Author Affiliations

CINCINNATI
Macy Foundation Student Fellow (Mr. Keller).; From the Departments of Pediatrics and Obstetrics, University of Cincinnati and the Cincinnati General Hospital, the Laboratory for the Study of Infant and Maternal Health, and the Children's Hospital Research Foundation.

Am J Dis Child. 1961;101(4):447-453. doi:10.1001/archpedi.1961.04020050037008
Abstract

An epidemic of apparent neonatal jaundice occurred with novobiocin administration to control a staphylococcal outbreak in a newborn nursery. The epidemic increase in clinical neonatal jaundice prompted studies and review of the relationship between novobiocin, so-called yellow novobiocin intermediary metabolites, and bilirubin.

Jaundice Epidemic in a Newborn Nursery  In early 1959, a staphylococcal outbreak was encountered in a term newborn nursery. The responsible organism was sensitive (disc sensitivity) to novobiocin but only partially sensitive to erythromycin. The outbreak was treated by administration of novobiocin to all infants admitted to the nursery. Every 8 hours, 50 gm. was given, a dose used in another local nursery during a similar outbreak.The number of clinically jaundiced infants increased during the period of novobiocin administration. This was documented by tabulation of infants with serum bilirubin determined to be over 15 mg. per 100 ml. during the period of novobiocin administration, during the preceding

First Page Preview View Large
First page PDF preview
First page PDF preview
×